APOBEC3A is a prominent cytidine deaminase in breast cancer.
APOBEC cytidine deaminases are the second-most prominent source of mutagenesis in sequenced tumors. Previous studies have proposed that APOBEC3B (A3B) is the major source of mutagenesis in breast cancer (BRCA). We show that APOBEC3A (A3A) is the only APOBEC whose expression correlates with APOBEC-in...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2019-12-01
|
| Series: | PLoS Genetics |
| Online Access: | https://doi.org/10.1371/journal.pgen.1008545 |
| _version_ | 1818588806436093952 |
|---|---|
| author | Luis M Cortez Amber L Brown Madeline A Dennis Christopher D Collins Alexander J Brown Debra Mitchell Tony M Mertz Steven A Roberts |
| author_facet | Luis M Cortez Amber L Brown Madeline A Dennis Christopher D Collins Alexander J Brown Debra Mitchell Tony M Mertz Steven A Roberts |
| author_sort | Luis M Cortez |
| collection | DOAJ |
| description | APOBEC cytidine deaminases are the second-most prominent source of mutagenesis in sequenced tumors. Previous studies have proposed that APOBEC3B (A3B) is the major source of mutagenesis in breast cancer (BRCA). We show that APOBEC3A (A3A) is the only APOBEC whose expression correlates with APOBEC-induced mutation load and that A3A expression is responsible for cytidine deamination in multiple BRCA cell lines. Comparative analysis of A3A and A3B expression by qRT-PCR, RSEM-normalized RNA-seq, and unambiguous RNA-seq validated the use of RNA-seq to measure APOBEC expression, which indicates that A3A is the primary correlate with APOBEC-mutation load in primary BRCA tumors. We also demonstrate that A3A has >100-fold more cytidine deamination activity than A3B in the presence of cellular RNA, likely explaining why higher levels of A3B expression contributes less to mutagenesis in BRCA. Our findings identify A3A as a major source of cytidine deaminase activity in breast cancer cells and possibly a prominent contributor to the APOBEC mutation signature. |
| first_indexed | 2024-12-16T09:30:36Z |
| format | Article |
| id | doaj.art-f1c296ed0cae4a369226dce379a509a1 |
| institution | Directory Open Access Journal |
| issn | 1553-7390 1553-7404 |
| language | English |
| last_indexed | 2024-12-16T09:30:36Z |
| publishDate | 2019-12-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Genetics |
| spelling | doaj.art-f1c296ed0cae4a369226dce379a509a12022-12-21T22:36:32ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042019-12-011512e100854510.1371/journal.pgen.1008545APOBEC3A is a prominent cytidine deaminase in breast cancer.Luis M CortezAmber L BrownMadeline A DennisChristopher D CollinsAlexander J BrownDebra MitchellTony M MertzSteven A RobertsAPOBEC cytidine deaminases are the second-most prominent source of mutagenesis in sequenced tumors. Previous studies have proposed that APOBEC3B (A3B) is the major source of mutagenesis in breast cancer (BRCA). We show that APOBEC3A (A3A) is the only APOBEC whose expression correlates with APOBEC-induced mutation load and that A3A expression is responsible for cytidine deamination in multiple BRCA cell lines. Comparative analysis of A3A and A3B expression by qRT-PCR, RSEM-normalized RNA-seq, and unambiguous RNA-seq validated the use of RNA-seq to measure APOBEC expression, which indicates that A3A is the primary correlate with APOBEC-mutation load in primary BRCA tumors. We also demonstrate that A3A has >100-fold more cytidine deamination activity than A3B in the presence of cellular RNA, likely explaining why higher levels of A3B expression contributes less to mutagenesis in BRCA. Our findings identify A3A as a major source of cytidine deaminase activity in breast cancer cells and possibly a prominent contributor to the APOBEC mutation signature.https://doi.org/10.1371/journal.pgen.1008545 |
| spellingShingle | Luis M Cortez Amber L Brown Madeline A Dennis Christopher D Collins Alexander J Brown Debra Mitchell Tony M Mertz Steven A Roberts APOBEC3A is a prominent cytidine deaminase in breast cancer. PLoS Genetics |
| title | APOBEC3A is a prominent cytidine deaminase in breast cancer. |
| title_full | APOBEC3A is a prominent cytidine deaminase in breast cancer. |
| title_fullStr | APOBEC3A is a prominent cytidine deaminase in breast cancer. |
| title_full_unstemmed | APOBEC3A is a prominent cytidine deaminase in breast cancer. |
| title_short | APOBEC3A is a prominent cytidine deaminase in breast cancer. |
| title_sort | apobec3a is a prominent cytidine deaminase in breast cancer |
| url | https://doi.org/10.1371/journal.pgen.1008545 |
| work_keys_str_mv | AT luismcortez apobec3aisaprominentcytidinedeaminaseinbreastcancer AT amberlbrown apobec3aisaprominentcytidinedeaminaseinbreastcancer AT madelineadennis apobec3aisaprominentcytidinedeaminaseinbreastcancer AT christopherdcollins apobec3aisaprominentcytidinedeaminaseinbreastcancer AT alexanderjbrown apobec3aisaprominentcytidinedeaminaseinbreastcancer AT debramitchell apobec3aisaprominentcytidinedeaminaseinbreastcancer AT tonymmertz apobec3aisaprominentcytidinedeaminaseinbreastcancer AT stevenaroberts apobec3aisaprominentcytidinedeaminaseinbreastcancer |